63 Million Shares traded since announcement, page-36

First 36 Last

Share
Profile

Follow
F18FDG

1,267 Posts.

197

06/04/18

08:37

Post #: 32260183
Share

Originally posted by bripoz ↑

Hey 3rd door...
"Everybody on this forum seems to think the Merck are getting the company for a steal"
That's because they are!!
We are not happy about that!!
But it's the best we have right now... a bird in the hand.
Cavatak, to my mind, is also extremely valuable to BMS... in combination with their drug.
There is plenty of time for them to make a higher offer(very slim chance).... only BMS know their own intent.
If they don't .... then $1.75 is what we have on the table.
What would that do to Merck's resolve?

Try selling your house for what you think it's worth... good luck on that one!

If a "no" vote should get up(an unlikely eventuality)... I will be very dirty, so I will NOW consider exiting at sub $1.75 prior to the voting process....as I believe the SP will get closer to $1.75 , with time decay.
If a "no" vote should then succeed I will be a very interested bystander watching the SP drop significantly (a no brainer)... whilst the "no" vote smarties continue to "smart..." as time passes without any further offers forthcoming AND ... while alien Clinical Trial Results from other entities dribble onto the market.
But then the "no" voters will have enjoyed the satisfaction of not selling because Merck would have obtained Cavatak for a steal.... and they ("no" voters) will have triumphed in the pyrrhic war.

"I dont think this is the maximum Merck would be willing to pay for the technology."
Yes it is ... if there is no rival bid. Do you really think Merck are not across the whole scenario.... and certainly light years more advanced than VLA shareholders' understanding of the state of affairs?

"A no vote is not final it just says the offer on the table is too low."
Agreed!... however, the absence of a rival bid reinforces Merck's confidence not to increase their $1.75 offer.
Further, the VLA Board are in full support of the offer.
Ask yourself why.
Even a 50c/share increase in the offer would translate to substantial increases to their individual net worth
Put yourself in Merck's position .... would you offer more?

"I can only make an informed decision when all the information is available".
I guess "all the information" refers to the 'deadline for a rival bid' having passed .

Expand

IMHO, the voting - no or otherwise - by aussie retail investors aint worth a hill 'o beans in the grand scheme of things.

Instos will decide the future of this business.

VLA Price at posting: $1.68 Sentiment: Hold Disclosure: Held
6 Upvote

0 Great analysis

Reply

Top Stories

AR3

Overland drilling proves promising for Australian Rare Earths' uranium hopes

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Trump is President Again: What Does This Mean for Crypto?

CPV

ClearVue inks deal with UK heated glass player to combine solar tech with its offering